Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Jenburkt Pharma Share Price

Jenburkt Pharmaceuticals Ltd.

₹1,012.90

5.35(0.53%)

Trade Now

2nd Apr 2026 | 3:22 PM

NSE :

Open Free Demat Account

Jenburkt Pharma Performance

Price Movement

N/A

₹982.00

₹1014.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹1,014.00

Low₹982.00

Open at₹982.00

Prev Close₹1,007.55

Volumes177

Avg Price₹997.94

Lower Circuit₹806.05

Upper Circuit₹1,209.05

Historical Performance

3M High₹1,168.90

3M Low₹944.00

1 Yr High₹1,410.00

1 Yr Low₹944.00

3 Yr High₹1,410.00

3 Yr Low₹586.90

5 Yr High₹1,410.00

5 Yr Low₹394.15

Jenburkt Pharma Fundamentals

Market Cap

Above industry Median

447 Cr.

PE Ratio (TTM)

Below industry Median

13.80

Dividend Yield

High in industry

1.80

Net Profit TTM

3.2% incr over last year

32.42

Net Profit Growth

3.2% incr over last year

32.42

PEG Ratio

High in industry

4.30

ROE

4.1% incr over last year

18.66

Operating Revenue TTM

165.16

Operating Revenue Growth

10.5% incr over last year

Book Value

Above industry Median

2.40

MFI

MFI is mid-range

47.45

RSI

RSI is mid-range

50.42

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

2.40

Jenburkt Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	43.02	45.56	35.53	41.05	36.89
Operating Expense	35.59	32.45	26.57	30.19	28.07
Operating Profit	7.43	13.10	8.96	10.86	8.82
Depreciation	0.83	0.74	0.72	0.79	0.78
Interest	0.12	0.11	0.11	0.11	0.11
Tax	2.37	4.17	2.39	3.30	3.01
Net Profit	5.93	10.16	7.79	8.54	6.51

Jenburkt Pharma Technicals

Jenburkt Pharmaceuticals Ltd. EMA & SMA

₹1012.90

5.35 (0.53%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1001.2

Day EMA10 ₹1001.1

Day EMA12 ₹1001.6

Day EMA20 ₹1005.8

Day EMA26 ₹1010

Day EMA50 ₹1029.6

Day EMA100 ₹1062.8

Day EMA200 ₹1090.6

Jenburkt Pharma Support and Resistance

Resistance

First Resistance₹1023.97

Second Resistance₹1034.98

Third Resistance₹1055.97

Support

First Support₹991.97

Second Support₹970.98

Third Support₹959.97

Technical Indicators

Day RSI50.42

Day MFI47.45

Day ADX29.22

Day Commodity Channel Index8.70

William-33.03

Day MACD-8.40

Day MACD Signal Line-10.65

Day ATR41.35

Day ROC125-6.81

Day ROC210.89

Jenburkt Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	46.7	46.7	46.7	46.7	46.7	46.6
FII	0	0	0	0	0	0
DII	0	0.1	0.1	0.1	0.1	0.1
Public	53.3	53.2	53.2	53.2	53.2	53.2

Jenburkt Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	607	946	64.16%
Week	936	1.23 K	76.36%
1 Month	810	994	81.53%
6 Month	1.09 K	1.54 K	70.94%

Jenburkt Pharma SWOT Analysis

Strengths12

Weakness8

Opportunity0

Threats1

MACD Crossover Above Signal Line

Price crossing above SMA20 today, and greater than SMA5

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

MACD crossed above signal line previous end of day

Top Gainers

Jenburkt Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
11 Jul, 2025	18	FINAL	11 Jul, 2025	Equity Share
23 Jul, 2024	15.3	FINAL		Equity Share
19 Jul, 2023	14.4	FINAL		Equity Share
21 Jul, 2022	12	FINAL		Equity Share
30 Aug, 2021	10.2	FINAL		Equity Share
18 Mar, 2020	8.1	INTERIM	19 Mar, 2020	Equity Share
22 Jul, 2019	10.2	FINAL		Equity Share
23 Jul, 2018	6	FINAL		Equity Share
27 Mar, 2018	3	INTERIM	28 Mar, 2018	Equity Share
21 Jul, 2017	8.1	FINAL		Equity Share

Jenburkt Pharma Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹201.95	₹37.60	₹5.80	₹89.80	₹345.05	₹108.50
% Change	-1.49%	1.98%	4.88%	-10.11%	-0.00%	2.54%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	56.00	-95.60	-1.40	11.90	76.40	27.40
1 Year Return		735.56	479	-29.73		-14.23
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.60

-0.42%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.20

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 59.50

+2.06%

APL

Asston Pharmaceuticals Ltd.

₹ 78.00

-1.02%

INFLUX

Influx Healthtech Ltd.

₹ 214.00

+0.19%

MEDIORG

Medicamen Organics Ltd.

₹ 23.25

+4.97%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 507.95

+1.69%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 31.79

+4.61%

SENORES

Senores Pharmaceuticals Ltd.

₹ 785.00

+1.48%

INNOVACAP

Innova Captab Ltd.

₹ 703.90

-0.01%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 56.10

-1.48%

SHELTER

Shelter Pharma Ltd.

₹ 29.35

-1.44%

TLL

Trident Lifeline Ltd.

₹ 263.50

-1.03%

DPL

Dipna Pharmachem Ltd.

₹ 9.00

-2.70%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.65

+0.53%

FABINO

Fabino Enterprises Ltd.

₹ 16.73

+4.96%

SUPRIYA

Supriya Lifescience Ltd.

₹ 611.00

+1.66%

SIGACHI

Sigachi Industries Ltd.

₹ 19.45

-0.10%

WINDLAS

Windlas Biotech Ltd.

₹ 766.00

-0.21%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+0.10%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 474.80

+3.42%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+2.27%

FAQ's on JENBURPH

What is the Market Capitalization of Jenburkt Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Jenburkt Pharmaceuticals Ltd. is approximately ₹ 447 Cr.

What are the PE and PB ratios for Jenburkt Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Jenburkt Pharmaceuticals Ltd. is 13.8, and the Price-to-Book (PB) ratio is 2.4.

What is the 52-Week High and Low for Jenburkt Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Jenburkt Pharmaceuticals Ltd. shares was ₹ 1410, and the lowest price was ₹ 944.

What is the current dividend yield for Jenburkt Pharmaceuticals Ltd.?

As of 6 June 2025, the dividend yield for Jenburkt Pharmaceuticals Ltd. is 1.8%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Jenburkt Pharmaceuticals Ltd.?

Significant shareholdings in Jenburkt Pharmaceuticals Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Jenburkt Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Jenburkt Pharmaceuticals Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

What is the latest dividend information for Jenburkt Pharmaceuticals Ltd.?

Jenburkt Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 18 per share for the financial period ending 2025. The record date was set as 2025-07-11, and the payment was/is scheduled around 2025-07-11. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy